Dr. Reddy's To Release Q1 FY13 Results On July 19, 2012

Dr. Reddy's Laboratories (NYSE: RDY) will announce results for the First Quarter ended June 30, 2012 on Thursday, July 19, 2012 after the Board Meeting. The results will be available on the Company’s website www.drreddys.com.

Summary of Events
Event       Date and Time (IST)       Medium
Release of financial results       July 19, after the Board Meeting      

Email, Media, Company website, Business Wire
Earnings Call       July 19, 6.30 PM IST / 9:00 AM EST       Hosted by the Company

(Details below)
Webcast of Earnings Call       July 19, 6.30 PM IST / 9.00 AM EST through July 24, 2012      

URL available on Company’s website,

www.drreddys.com
Transcripts of the Earnings call       Will be available on the Company’s website      

URL available on Company’s website, www.drreddys.com
           

Earnings Call

Following the release, the management of the Company will host an earnings call to discuss the Company’s financial performance.
Conference Dial-In Numbers
Primary Number:       +91 22 3065 0136
Secondary Number:       +91 22 6629 0356
The numbers listed above are universally accessible from all networks and all countries.
Local Access Number:      

6000 1221 Available in - Delhi, Bangalore, Chennai, Hyderabad, Kolkata Accessible from all major carriers except BSNL/MTNL.

3940 3977

Available in - Gurgaon (NCR), Bangalore, Kolkata, Cochin, Pune,Lucknow, Ahmedabad, Chandigarh

Accessible from all carriers.
International Toll Free Number:       USA: 1 866 746 2133

UK: 0 808 101 1573

Singapore: 800 101 2045

Hong Kong: 800 964 448
 

No password/pin number is necessary to dial in to any of the other calls. As participation in the call is limited, early registration is encouraged. The operator will provide instructions on asking questions before and during the call.

If you liked this article you might like

Generics Drop Across Board as DOJ Inquiry Expands

Teva Divests More Assets to Win EC Approval for Allergan Generics Deal

Changing Landscape for Generic-Drug Makers Creates Opportunities

Dr Reddy's Laboratories (RDY) Highlighted As Weak On High Volume

Ex-Dividend Alert: 3 Stocks Going Ex-Dividend Tomorrow: GLV, GLO, RDY